^
    Back
    Association details:
    Biomarker:No biomarker
    Cancer:Pancreatic Adenocarcinoma
    Regimen:FOLFIRI
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: A2 - Guideline
    Source:
    NCCN
    Published date:
    05/04/2023
    Excerpt:
    Pancreatic Adenocarcinoma….PRINCIPLES OF SYSTEMIC THERAPY….Useful in Certain Circumstances...If previous first-line FOLFIRINOX: 5-FU + leucovorin + irinotecan (FOLFIRI)